Commentary
Commentary
Coronavirus deregulating health care — this should continue after pandemic is beaten
In response to the coronavirus outbreak, the Centers for Medicare and Medicaid Services has rolled back regulations on hospitals and health care providers. Hospitals are no longer barred from treating COVID-19 patients in outpatient facilities. The feds are also freeing nurse practitioners, physician assistants and medical residents to provide more care on their own. ...
Commentary
The Medicare Bureaucracy Is Unnecessarily Putting Kidney Patients At Risk
The Centers for Disease Control and Prevention (CDC) has issued guidance for healthcare facilities in response to the COVID-19 virus including asking all U.S. healthcare facilities to “explore alternatives to face-to-face triage and visits.” The CDC has issued this recommendation to help contain the spread of the virus, protect healthcare workers from ...
Commentary
Telehealth should stay long after COVID-19 goes
The new coronavirus outbreak has put enormous pressure on the American health care system. In response, federal officials and private insurers have rushed to improve patient access to video consultations and other forms of virtual care. It may have taken a public health emergency to bring “telehealth” to the mainstream, ...
Commentary
Optimism About a Speedy Coronavirus Vaccine Is Misplaced
As the outbreak of the novel coronavirus continues to gain momentum in the United States, there is intense interest in the development of a vaccine. Several US drugmakers have begun working on a vaccine, independently or with federal agencies like the National Institutes of Health. The public is hungry for ...
Commentary
Private sector working to ensure it doesn’t get worse before it gets better
The federal government’s efforts to combat the ongoing coronavirus pandemic illustrate why we shouldn’t put our full trust in government to find a cure. After all, they badly botched the testing, costing valuable time in identifying new cases and limiting its spread. Fortunately, private-sector innovators are leading where government has ...
California
Coronavirus Shows State Push for Public Transit is Hazardous to our Health
On March 11, 2020, the Legislative Analyst’s Office published a handout, which included a passage on the climate benefits of mass transit over private vehicles. Within days, a spreading virus made the case that our cars are a more hygienic means of travel than public transportation, where humanity is crammed ...
Commentary
Dr. Henry Miller Discusses Coronavirus Delaying Cancer Patient Treatments
Title: COVID-19 Pandemic Delaying Treatments of Hematologic Cancers By: John Schieszer Institutional restrictions due to the coronavirus disease 2019 (COVID-19) pandemic are taking a large toll on patients with hematologic cancers. Some medical centers have canceled treatments and all centers have altered their policies and procedures. Starting in March, elective ...
Commentary
Dr. Henry Miller Answers Viewer Questions as Featured Expert on Fox News Live Blog
Read answers from PRI Senior Fellow Dr. Henry Miller on Foxnews.com’s “Coronavirus Live Blog.” Dr. Miller answered written questions on Wednesday, April 1 about the coronavirus, next steps, and more. Read Dr. Miller’s responses here: https://www.foxnews.com/health/coronavirus-live-blog-former-fda-official-dr-henry-miller.
Charter Schools
Coronavirus school shutdowns foster online learning alternatives
Along with other sectors of society, education has been greatly affected by the coronavirus, with schools closed across America. Yet, as in other fields, innovators in education have responded with learning mechanisms and models that allow students to continue to learn while the country shuts down brick-and-mortar institutions. As it ...
Commentary
Expand Pharmacists’ Authority To Promote Access To Forthcoming COVID-19 Vaccine
Private pharmaceutical companies and the National Institutes of Health have outdone themselves. Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies ...
Coronavirus deregulating health care — this should continue after pandemic is beaten
In response to the coronavirus outbreak, the Centers for Medicare and Medicaid Services has rolled back regulations on hospitals and health care providers. Hospitals are no longer barred from treating COVID-19 patients in outpatient facilities. The feds are also freeing nurse practitioners, physician assistants and medical residents to provide more care on their own. ...
The Medicare Bureaucracy Is Unnecessarily Putting Kidney Patients At Risk
The Centers for Disease Control and Prevention (CDC) has issued guidance for healthcare facilities in response to the COVID-19 virus including asking all U.S. healthcare facilities to “explore alternatives to face-to-face triage and visits.” The CDC has issued this recommendation to help contain the spread of the virus, protect healthcare workers from ...
Telehealth should stay long after COVID-19 goes
The new coronavirus outbreak has put enormous pressure on the American health care system. In response, federal officials and private insurers have rushed to improve patient access to video consultations and other forms of virtual care. It may have taken a public health emergency to bring “telehealth” to the mainstream, ...
Optimism About a Speedy Coronavirus Vaccine Is Misplaced
As the outbreak of the novel coronavirus continues to gain momentum in the United States, there is intense interest in the development of a vaccine. Several US drugmakers have begun working on a vaccine, independently or with federal agencies like the National Institutes of Health. The public is hungry for ...
Private sector working to ensure it doesn’t get worse before it gets better
The federal government’s efforts to combat the ongoing coronavirus pandemic illustrate why we shouldn’t put our full trust in government to find a cure. After all, they badly botched the testing, costing valuable time in identifying new cases and limiting its spread. Fortunately, private-sector innovators are leading where government has ...
Coronavirus Shows State Push for Public Transit is Hazardous to our Health
On March 11, 2020, the Legislative Analyst’s Office published a handout, which included a passage on the climate benefits of mass transit over private vehicles. Within days, a spreading virus made the case that our cars are a more hygienic means of travel than public transportation, where humanity is crammed ...
Dr. Henry Miller Discusses Coronavirus Delaying Cancer Patient Treatments
Title: COVID-19 Pandemic Delaying Treatments of Hematologic Cancers By: John Schieszer Institutional restrictions due to the coronavirus disease 2019 (COVID-19) pandemic are taking a large toll on patients with hematologic cancers. Some medical centers have canceled treatments and all centers have altered their policies and procedures. Starting in March, elective ...
Dr. Henry Miller Answers Viewer Questions as Featured Expert on Fox News Live Blog
Read answers from PRI Senior Fellow Dr. Henry Miller on Foxnews.com’s “Coronavirus Live Blog.” Dr. Miller answered written questions on Wednesday, April 1 about the coronavirus, next steps, and more. Read Dr. Miller’s responses here: https://www.foxnews.com/health/coronavirus-live-blog-former-fda-official-dr-henry-miller.
Coronavirus school shutdowns foster online learning alternatives
Along with other sectors of society, education has been greatly affected by the coronavirus, with schools closed across America. Yet, as in other fields, innovators in education have responded with learning mechanisms and models that allow students to continue to learn while the country shuts down brick-and-mortar institutions. As it ...
Expand Pharmacists’ Authority To Promote Access To Forthcoming COVID-19 Vaccine
Private pharmaceutical companies and the National Institutes of Health have outdone themselves. Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies ...
